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Abstract Two classes of chaperonins are known in all groups
of organisms to participate in the folding of newly synthesized
proteins. Whereas bacterial type I chaperonins use a reversibly
binding cofactor to temporarily sequester folding substrate
proteins within the cylindrical chaperonin cavity, type II
chaperonins in archaea and the eukaryotic cytosol appear to
have evolved a built-in lid for this purpose. Not entirely sur-
prisingly, this has consequences for the folding modes of the
two types of chaperonins. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Protein folding in the cell requires the assistance of molec-
ular chaperones [1]. The chaperonins, a sub-group of molec-
ular chaperones found in all domains of life, comprise a fam-
ily of ATPases of roughly 60 kDa that assemble into twin
rings, stacked back-to-back, with a large central cavity where
unfolded polypeptides may bind and undergo productive fold-
ing (Fig. 1) [2]. Based on their evolutionary origin, chaper-
onins can be grouped into two distinct classes. Type I chaper-
onins, found in the bacterial cytosol and in endosymbiont-
derived organelles of eukaryotes, form heptameric rings and
are represented by bacterial GroEL, mitochondrial hsp60, and
chloroplast cpn60. Type II chaperonins, present in the eukary-
otic cytoplasm and in archaea, include the archaeal thermo-
some and the eukaryotic CCT (chaperonin containing TCP-1)
[3,4]. Thermosome rings are eight- or nine-membered, and
consist of one to three subunit types [3,5,6]. CCT rings consist
of eight subunits, each the product of an essential gene [7].
The crystal structures of Escherichia coli GroEL and the ther-
mosome from Thermoplasma acidophilum reveal that all chap-
eronins share a similar domain architecture [5,8,9]. An equa-
torial domain forms the interface between individual rings and
is the site of ATP binding and hydrolysis, and substrate pro-
tein binds at the central face of the apical domain, and the
two are connected by a short intermediate domain. GroEL is
the best studied chaperonin and its mechanism of action is
understood in some detail (Fig. 1). Our understanding of type
II chaperonins currently lags behind that of GroEL, but the
emerging picture suggests a degree of similarity in the ATP-
driven folding cycle among all chaperonins [10]. However, the
two classes of chaperonins also di¡er from each other in sev-
eral important respects. In this minireview, we highlight the
salient features of chaperonin structure and function while
pointing out the known similarities and di¡erences between
the two classes (Table 1).
2. Type I chaperonins ^ a separate lid for protein folding inside
the cylinder cavity
GroEL, like all type I chaperonins, is assisted in its function
by a 10 kDa cochaperonin, GroES, that assembles into a
heptamer [11,12]. GroES ful¢lls two functions: it acts as a
lid to seal o¡ the folding chamber and helps displace bound
substrate protein into the cavity where it can undergo folding.
The nucleotide-dependent interaction between GroEL and
GroES has been well characterized. A £exible motif within
the cochaperonin subunit, called the mobile loop [13], medi-
ates its binding to a well-de¢ned region in the apical domain
of GroEL [9] which also forms part of the hydrophobic sur-
face responsible for binding of substrate proteins [14]. The
fact that GroES is essential in vivo [15] supports the view
that a sealed cavity is necessary for successful folding of a
signi¢cant number of substrate proteins to the native state,
or at least to a form that is committed to reaching the native
conformation. In the absence of GroES, substrate proteins
can escape the chaperonin in an unfolded form that is prone
to aggregation [16]. Although some model substrate proteins
used in in vitro studies can be refolded from GroEL under
such conditions, these are proteins that are quite capable of
folding spontaneously in bulk solution on their own if re-
leased from GroEL without GroES [16]. For these ‘non-strin-
gent’ substrates, encapsulation in the folding cavity is a moot
point, possibly even in vivo.
The GroES-sealed cavity encloses a volume of 175 000 Aî 3,
su⁄ciently large to encapsulate a polypeptide of approxi-
mately 60 kDa [9]. However, proteins larger than 60 kDa
have also been shown to interact with GroEL by coimmuno-
precipitation and sodium dodecyl sulfate^polyacrylamide gel
electrophoresis [17]. Whether these represent bona ¢de sub-
strates and, if so, how GroEL deals with them, is not known.
The volume of the GroES-sealed cavity is actually twice the
volume of the cavity in unliganded GroEL [8,9]. To achieve
this increase, GroEL undergoes profound conformational
changes, which can be thought of as three rigid body move-
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ments occurring about two hinges (Fig. 2). They include: (1) a
25‡ downward movement of the intermediate domain which
clamps down on the nucleotide binding site of the equatorial
domain, (2) a 60‡ upward displacement of the apical domain
relative to the vertical, and (3) a 90‡ clockwise rotation of the
apical domain about its longitudinal axis. These domain
movements are driven by binding and hydrolysis of ATP,
and are essential for the distinct events occurring during the
chaperonin reaction cycle.
During such a cycle (Fig. 1), binding of seven molecules of
ATP to the substrate-containing ring is followed immediately
by the binding of GroES to the same, or cis, ring [18,19]. The
bound substrate is thus released into the cavity, which is
sealed by the cochaperonin. While inside the cavity, the pro-
tein has about 10^20 s to fold [20], after which the seven ATP
molecules are hydrolyzed and the GroEL^GroES complex
relaxes into a conformation that is ready to dissociate [21].
Binding of seven ATP to the opposite, or trans, ring causes
the dissociation of GroES from GroEL, thereby allowing the
substrate protein to be released [22]. In the absence of sub-
strate, the rate-limiting step is the aforementioned relaxation
of the GroEL^GroES complex, while in the presence of sub-
strate, it is nucleotide hydrolysis itself [21].
Two levels of cooperativity in both binding and hydrolysis
of ATP have been observed for GroEL in vitro, and there is
emerging evidence that cooperativity is necessary for proper
chaperonin function in vivo [23]. First, there exists positive
cooperativity within a given ring [24,25]. Positive cooperativ-
ity would presumably serve to ensure an all-or-none switch in
conformation required to both bind GroES and release sub-
strate protein into the cavity. This is important in light of the
fact that substrate proteins interact with several subunits of
Fig. 1. Chaperonin reaction cycles. Top panel: Type I chaperonins. The binding of substrate protein to one chaperonin ring (I) is followed by
the binding of cochaperonin (GroES) and seven molecules of ATP to the same ring (II). The substrate is released into the now-closed cavity
and has 10^20 s of folding time before ATP is hydrolyzed (III). Following hydrolysis, the binding of seven molecules of ATP to the opposite
ring triggers the dissociation of the cochaperonin and the release of folded substrate protein (IV). Bottom panel: Type II chaperonins. Sub-
strate protein is bound at the apical domains, possibly involving the helical protrusions (I). Binding of eight molecules of ATP then results in
rotation of the apical domains to face the cavity (II). Closure of the cavity and release of the bound substrate protein into the interior to fold
presumably requires hydrolysis of ATP (III). An ^ as yet ^ unknown signal triggers the opening of the chaperonin cavity and release of the
folded substrate (IV). The color-coding of the various components is as follows: chaperonin equatorial domain (red), intermediate domain (yel-
low), and apical domain (dark green); cochaperonin and helical protrusions (light green); unfolded substrate protein (light blue); folded sub-
strate protein (dark blue).
Table 1
Features of type I and type II chaperonins
Chaperonin features Type I chaperonins Type II chaperonins
CCT Thermosome
Number of subunits per chaperonin ring 7 8 8 or 9
Di¡erent subunits per complex generally 1^2 8 1^3
Lid function separate cochaperonin (GroES) built-in lid
Volume of closed cavity 175 000 Aî 3 130 000 Aî 3
ATP binding mode concerted (MWC model) sequential? (KNF model) N/A
Positive intra-ring cooperativity yes yes N/A
Negative inter-ring cooperativity yes yes yes?
Folding mode post-translational mostly cotranslational N/A
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GroEL simultaneously [26]. Second, information is conveyed
between the two rings in the form of negative cooperativity
[25] such that the occupancy of one ring by ATP decreases the
a⁄nity of the second ring for ATP. GroEL has been described
as a ‘two-stroke’ motor in which each ring takes turn in being
‘folding-active’, and it may be that negative cooperativity con-
tributes to this directionality in the chaperonin folding cycle
[27,28].
3. Type II chaperonins ^ made with a built-in lid
One important way in which type II chaperonins di¡er from
their type I brethren is in the absence of a partner cochaper-
onin. So, how do type II chaperonins keep a lid on events
occurring inside the folding cavity? The ¢rst clue came from
the crystal structure of the isolated apical domain of the
T. acidophilum thermosome [29]. The structure made it imme-
diately apparent that a helical region present in the thermo-
some, but absent in GroEL, protruded towards what would
be the center of the cavity in an intact chaperonin. This ‘hel-
ical protrusion’ was proposed to act as a built-in lid, and the
presence of conserved hydrophobic residues in the protrusion
also made it a candidate for the region involved in substrate
binding [29]. The crystal structure of the complete thermo-
some con¢rmed the prediction that the protrusion could close
o¡ the cavity [5]. Interestingly, the structure also showed that
a portion of the protrusion, which was helical in the isolated
apical domain, now adopted a L-strand conformation. Taken
together, the crystal structures and accompanying electron
microscopy [30,31] made it attractive to envision the following
model (Fig. 2). In one conformation, the protrusion would be
facing away from the cavity, thereby exposing the hydropho-
bic residues for binding. In another conformation, the protru-
sion would occlude the cavity, thereby encapsulating the sub-
strate protein and releasing it into the interior to fold. Though
the role of the protrusion as built-in lid has gained acceptance,
it should be pointed out that its role as substrate-binding site
has yet to be demonstrated. Results from cryoelectron micros-
copy studies of CCT^tubulin and CCT^actin substrate protein
complexes indicate that even though tubulin appears bound at
the level of the protrusions, actin appears to be bound well
below them [32,33].
To isolate a substrate protein in the closed cavity is ex-
pected to increase the folding yield because it would eliminate
unproductive side reactions, such as aggregation. The volume
of the closed cavity in type II chaperonins has been estimated
to be approximately 130 000 Aî 3, placing a size exclusion limit
of about 50 kDa on proteins that can be fully encapsulated
[5]. Yet, CCT has been shown to fold larger proteins, such as
luciferase [4]. Additionally, a recent ¢nding demonstrated that
actin and tubulin could be folded just as e⁄ciently by a CCT
in which the cavity was partially occupied by a monoclonal
antibody directed against one of the chaperonin subunits [34].
The authors raised the possibility that folding by type II chap-
eronins may not require complete closure of the cavity. Would
this be compatible with the role of CCT in vivo? It is known
that CCT is associated with translating ribosomes [35] and
that folding of proteins in eukaryotes occurs mostly cotransla-
tionally [36]. CCT has also been shown to interact with nas-
cent chains as they are extruded from the protein synthesis
machinery, and to participate in their folding to the native
state [35,37]. CCT need not accept the substrate protein di-
rectly from the ribosome, as nascent chains can interact with
other chaperones ¢rst (such as hsp70 and prefoldin) before
being delivered to the chaperonin [35,38]. If a polypeptide
chain is being continuously fed from the ribosome, to which
it is still attached via its C-terminus, one could envision the
need to keep the cavity open in order to accommodate the
growing protein. A detachable lid, like GroES, would then
interfere with the threading of polypeptide to the chaperonin.
The rate of ATP turnover by CCT in vitro is anemic com-
pared to GroEL (0.0119^0.0183 s31 vs. 0.27^0.40 s31 for sin-
gle and double rings, respectively) [39]. However, the presence
of denatured substrate protein has been shown to increase this
rate up to eight-fold [40], leading to a CCT single-ring turn-
over time of 70 s. A current model holds that de novo protein
folding in eukaryotes proceeds in a domain-wise manner, with
contiguous domains folding individually as they emerge from
the ribosome (reviewed in [41]). Given the eukaryotic trans-
lation rate of approximately ¢ve amino acids per second, a
150^300 amino acid domain would take 30^60 s to be synthe-
sized, well within the 70 s window of opportunity for one turn
of the chaperonin cycle. CCT could then cycle between open
and (partially) closed states, thereby gobbling up successive
stretches of polypeptide in a ‘pac-man’-like fashion as they
come o¡ the ribosome. While CCT may thus be very well
suited to cotranslational folding, bacterial GroEL is not re-
cruited to translating ribosomes and has been demonstrated to
act post-translationally [42]. A detachable lid is therefore of
no concern with regards to interference during bacterial trans-
lation. Furthermore, the complete closure of the cavity by
GroES is actually bene¢cial given that bacterial translation
proceeds at a much more rapid pace (about 10 times faster
than in eukaryotes), and protein folding is thought to be
largely, although not necessarily exclusively, post-translational
[36,41]. Without the added security that the tethering of a
folding nascent protein to the ribosome provides in eukary-
Fig. 2. Domain movements occurring during the open-to-closed
transition of the chaperonin reaction cycles. A: Side-view of a type
I chaperonin subunit. The downward 25‡ rotation of the intermedi-
ate domain (yellow) precedes the upward 60‡ displacement and 90‡
clockwise rotation of the apical domain (green). B: Top-view of the
eight apical domains in a type II chaperonin ring. A 70‡ clockwise
rotation of the apical core domains (dark green) orients the helical
protrusions (light green) towards the center of the cavity. To com-
pletely seal o¡ the cavity, the apical domains also tilt 30‡ down-
wards (not shown).
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otes, it may become more bene¢cial to prevent premature
escape of an unfolded protein by completely sealing o¡ the
GroEL cavity.
4. Chaperonins and nucleotides C open or closed?
As mentioned above, the crystal structure of the thermo-
some shows the chaperonin in a fully closed conformation,
with the helical protrusions in both rings pointing towards
the center of the cavity [5]. What stage of the chaperonin cycle
does this structure actually represent? Cryoelectron tomogra-
phy and microscopy of nucleotide-free type II chaperonins
reveal them to be in an open conformation with the helical
protrusions contacting the apical domains of neighboring sub-
units, thereby giving substrate protein full access to the central
cavity in both rings [30]. The ATP-bound form of CCT is
even slightly more open than the nucleotide-free form
[31,43]. In contrast to a nucleotide-free CCT, the apical do-
mains in an ATP-bound ring are rotated 70‡ clockwise such
that their tips now face the central cavity, and the equatorial
domain moves out slightly (Fig. 2). Although the helical pro-
trusions were not resolved in structural data of ATP-bound
CCT [31], they remain sensitive to proteolysis [44], indicating
that ATP hydrolysis is required to drive the chaperonin into
the fully closed state where the protrusions are protected and
fully cover the cavity. There is evidence to suggest that in the
absence of substrate protein, the rate-limiting step of the ther-
mosome ATPase activity is a slow, post-hydrolysis isomeriza-
tion into a closed ADP-Pi state prior to phosphate release
[43,45]. Whether this is also the case in the presence of sub-
strate protein is not known. In order to progress into this fully
closed form, the apical domains would have to tilt 30‡ down-
ward [46]. Therefore, the thermosome rings in the crystal
structure likely represent the chaperonin in an ADP-Pi con-
formation. Another conformation, one in which one ring is
open and the other is closed, has been recently observed for
thermosomes from two di¡erent species of archaea [46,47].
This asymmetrical, bullet-shaped conformation is highly rem-
iniscent of the asymmetrical GroES-bound GroEL complex.
Our understanding of the ATPase cycle of type II chaper-
onins (Fig. 1) is not as detailed yet as that of GroEL. Despite
the fact that the greatest degree of sequence similarity among
all chaperonins lies in the equatorial domain, which contains
the nucleotide binding pocket, di¡erences between the two
classes have begun to emerge. For example, the chaperonins
di¡er in their monovalent cation requirements for ATP hy-
drolysis [2,10]. Analogous to GroEL, two levels of coopera-
tivity have recently been reported for CCT [39]. However, the
value of the Hill coe⁄cient for the positive cooperativity ex-
isting within each ring, was lower for CCT than for GroEL
under identical conditions. The authors suggest that this
might be due to the di¡erent a⁄nities of the eight distinct
CCT subunits for ATP [39]. It has been proposed that a
hierarchy exists among the CCT subunits in terms of ATP
binding [48] which correlates well with the speci¢c order in
which the subunits are arranged within a ring [49]. Such a
hierarchy implies that the binding of ATP to CCT, and the
conformational changes that accompany it, may be sequential
(KNF model of cooperativity) rather than all-or-none as pro-
posed for GroEL. In contrast, the negative cooperativity that
was found to exist between the two CCT rings was consider-
ably stronger than that which exists in type I chaperonins [39].
Furthermore, unlike in GroEL, the binding of ATP to the
second ring appears not to decrease the maximal ATPase
activity of CCT [39] ; the ATPase activity nearly doubles in-
stead. It would appear that the nature of the inter-ring com-
munication may not be the same for type I and II chaper-
onins. Perhaps this is not surprising given the di¡erent
quaternary arrangement of the subunits between the two
classes. Whereas the subunits between two rings in type I
chaperonins are staggered, they are aligned in register in
type II chaperonins [5,8,9].
A wealth of information concerning chaperonin function
has emerged over the past decade, with GroEL at the fore-
front. To complete the picture, the spotlight has begun to shift
to type II chaperonins. Based on current data, the emerging
synthesis of type I and type II chaperonin function will likely
highlight two ingenious, albeit di¡erent solutions that have
evolved to arrive at e⁄cient protein folding inside a cylindri-
cal cavity.
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